Kindra Clark‐Snustad

411 total citations
31 papers, 273 citations indexed

About

Kindra Clark‐Snustad is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Kindra Clark‐Snustad has authored 31 papers receiving a total of 273 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Genetics, 21 papers in Epidemiology and 11 papers in Surgery. Recurrent topics in Kindra Clark‐Snustad's work include Inflammatory Bowel Disease (25 papers), Microscopic Colitis (16 papers) and Eosinophilic Esophagitis (6 papers). Kindra Clark‐Snustad is often cited by papers focused on Inflammatory Bowel Disease (25 papers), Microscopic Colitis (16 papers) and Eosinophilic Esophagitis (6 papers). Kindra Clark‐Snustad collaborates with scholars based in United States, Belgium and Japan. Kindra Clark‐Snustad's co-authors include Scott D. Lee, Chelle L. Wheat, Cynthia W. Ko, David Grembowski, Beth Devine, Timothy A. Thornton, Kendra Kamp, Anand Singla, Jason Harper and Anita Afzali and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Clinical Pharmacology & Therapeutics.

In The Last Decade

Kindra Clark‐Snustad

27 papers receiving 272 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kindra Clark‐Snustad United States 7 170 134 66 66 46 31 273
David Choi United States 10 142 0.8× 107 0.8× 44 0.7× 23 0.3× 52 1.1× 43 237
Davide Massimi Italy 11 125 0.7× 119 0.9× 88 1.3× 45 0.7× 77 1.7× 43 346
Melek Simsek Netherlands 11 116 0.7× 61 0.5× 36 0.5× 13 0.2× 42 0.9× 24 283
Mingqing Song United States 9 52 0.3× 84 0.6× 90 1.4× 42 0.6× 141 3.1× 19 358
Ana Vieira Portugal 9 222 1.3× 154 1.1× 91 1.4× 19 0.3× 81 1.8× 12 301
Maja Ideström Sweden 5 188 1.1× 125 0.9× 103 1.6× 25 0.4× 85 1.8× 8 304
Ariela Holmer United States 8 206 1.2× 150 1.1× 61 0.9× 76 1.2× 71 1.5× 13 342
João Freitas Portugal 10 172 1.0× 136 1.0× 46 0.7× 23 0.3× 94 2.0× 15 280
Lena Thin Australia 7 86 0.5× 106 0.8× 35 0.5× 22 0.3× 81 1.8× 24 192
Ágnes Milassin Hungary 10 164 1.0× 129 1.0× 136 2.1× 65 1.0× 104 2.3× 41 343

Countries citing papers authored by Kindra Clark‐Snustad

Since Specialization
Citations

This map shows the geographic impact of Kindra Clark‐Snustad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kindra Clark‐Snustad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kindra Clark‐Snustad more than expected).

Fields of papers citing papers by Kindra Clark‐Snustad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kindra Clark‐Snustad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kindra Clark‐Snustad. The network helps show where Kindra Clark‐Snustad may publish in the future.

Co-authorship network of co-authors of Kindra Clark‐Snustad

This figure shows the co-authorship network connecting the top 25 collaborators of Kindra Clark‐Snustad. A scholar is included among the top collaborators of Kindra Clark‐Snustad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kindra Clark‐Snustad. Kindra Clark‐Snustad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Scott D., et al.. (2025). Upadacitinib Results in Endoscopic Remission in Patients With Inflammatory Bowel Disease and Prior Tofacitinib Failure. Journal of Clinical Gastroenterology. 60(4). 356–362.
2.
Kamp, Kendra, K Hendrickson, Asif Iqbal, et al.. (2025). Correlation of Fecal, Plasma, Serum, and Salivary Calprotectin to Endoscopic and Histologic Outcomes in Patients With Crohn’s Disease. Gastroenterology Nursing. 48(4). 265–270.
3.
Rosenfeld, Sam, Kindra Clark‐Snustad, Kendra Kamp, et al.. (2023). SAFETY AND EFFICACY OF MYCOPHENOLATE MOFETIL TREATMENT FOR REFRACTORY CROHN'S DISEASE. Inflammatory Bowel Diseases. 29(Supplement_1). S84–S84. 1 indexed citations
4.
Kamp, Kendra, Kindra Clark‐Snustad, Kevin C. Cain, et al.. (2023). A Comprehensive Self-Management Intervention for Inflammatory Bowel Disease (CSM-IBD): Protocol for a Pilot Randomized Controlled Trial. JMIR Research Protocols. 12. e46307–e46307. 2 indexed citations
5.
Kamp, Kendra, Kindra Clark‐Snustad, Robert L. Burr, et al.. (2023). Relationship of Sleep Health and Endoscopic Disease Activity in Inflammatory Bowel Disease. Gastroenterology Nursing. 46(6). 465–474. 5 indexed citations
6.
Kamp, Kendra, et al.. (2022). Relationship Between Endoscopic and Clinical Disease Activity With Fatigue in Inflammatory Bowel Disease. Gastroenterology Nursing. 45(1). 21–28. 3 indexed citations
7.
Alayo, Quazim A., Osama Altayar, Kerri Glassner, et al.. (2022). Systematic Review With Meta-analysis: Safety and Effectiveness of Combining Biologics and Small Molecules in Inflammatory Bowel Disease. Crohn s & Colitis 360. 4(1). otac002–otac002. 57 indexed citations
8.
Kamp, Kimberly, Na Li, Daniel M. Lachance, et al.. (2022). Interpersonal Variability in Gut Microbial Calprotectin Metabolism. SHILAP Revista de lepidopterología. 1(5). 853–856. 3 indexed citations
9.
Lee, Scott D., et al.. (2022). Tofacitinib Appears Well Tolerated and Effective for the Treatment of Patients with Refractory Crohn’s Disease. Digestive Diseases and Sciences. 67(8). 4043–4048. 5 indexed citations
10.
11.
Lee, Scott D., et al.. (2021). Pustular Rash in Crohn’s Patient on Ustekinumab Raises Concern for Drug-Induced Paradoxical Psoriasis. SHILAP Revista de lepidopterología. 15(2). 662–666. 4 indexed citations
12.
Clark‐Snustad, Kindra, et al.. (2020). Women’s Health and Ulcerative Colitis. Gastroenterology Clinics of North America. 49(4). 769–789. 10 indexed citations
13.
14.
15.
Billington, Sarah, Steven C. Shoner, Scott D. Lee, et al.. (2019). Positron Emission Tomography Imaging of [11C]Rosuvastatin Hepatic Concentrations and Hepatobiliary Transport in Humans in the Absence and Presence of Cyclosporin A. Clinical Pharmacology & Therapeutics. 106(5). 1056–1066. 50 indexed citations
16.
Clark‐Snustad, Kindra, Anand Singla, & Scott D. Lee. (2019). Su1928 – Tofacitinib Improves Clinical Disease Activity in a Real-World Population of Patients with Moderate-Severe Ulcerative Colitis and Crohn’s Disease. Gastroenterology. 156(6). S–664. 11 indexed citations
17.
Clark‐Snustad, Kindra, et al.. (2019). Efficacy of Infliximab in Crohn’s Disease Patients with Prior Primary-Nonresponse to Tumor Necrosis Factor Antagonists. Digestive Diseases and Sciences. 64(7). 1952–1958. 5 indexed citations
18.
Osterman, Mark T., et al.. (2018). P136 CERTOLIZUMAB PEGOL IS EFFECTIVE IN THE MAINTENANCE OF RESPONSE IN MODERATE-SEVERE ULCERATIVE COLITIS: AN OPEN-LABEL MAINTENANCE STUDY. Gastroenterology. 154(1). S71–S71. 3 indexed citations
19.
Wheat, Chelle L., Cynthia W. Ko, Kindra Clark‐Snustad, et al.. (2017). Inflammatory Bowel Disease (IBD) pharmacotherapy and the risk of serious infection: a systematic review and network meta-analysis. BMC Gastroenterology. 17(1). 52–52. 47 indexed citations
20.
Wheat, Chelle L., Kindra Clark‐Snustad, Beth Devine, et al.. (2016). Worldwide Incidence of Colorectal Cancer, Leukemia, and Lymphoma in Inflammatory Bowel Disease: An Updated Systematic Review and Meta-Analysis. Gastroenterology Research and Practice. 2016. 1–18. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Choi Breakdown of academic impact, for papers by Davide Massimi Breakdown of academic impact, for papers by Melek Simsek Breakdown of academic impact, for papers by Mingqing Song Breakdown of academic impact, for papers by Ana Vieira Breakdown of academic impact, for papers by Maja Ideström Breakdown of academic impact, for papers by Ariela Holmer Breakdown of academic impact, for papers by João Freitas Breakdown of academic impact, for papers by Lena Thin Breakdown of academic impact, for papers by Ágnes Milassin
Rankless by CCL
2026